Facense is developing smart glasses with small thermal and CMOS sensors to measure vital signs unobtrusively and continuously. Facense's technology enables the detection and prediction of various medical conditions including hypertension, stroke, asthma, and congestive heart failure. Facense started filing for patents in 2016 and now owns an extensive portfolio, which is available for licensing. The company is looking to cooperate with smart glasses/AR/VR manufacturers.
| Loading Documents... |
